Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

A randomised, multi-centre trial of total ankle replacement versus ankle arthrodesis in the treatment of patients with end stage ankle osteoarthritis (TARVA): statistical analysis plan.

Muller P, Skene SS, Chowdhury K, Cro S, Goldberg AJ, Doré CJ; TARVA Study Group.

Trials. 2020 Feb 18;21(1):197. doi: 10.1186/s13063-019-3973-4.

2.

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.

Jones A, Muller P, Dore CJ, Ikeji F, Caverly E, Chowdhury K, Isenberg DA, Gordon C, Ehrenstein MR.

BMJ Open. 2019 Dec 16;9(12):e032569. doi: 10.1136/bmjopen-2019-032569.

3.

Transcriptomically Guided Mesendoderm Induction of Human Pluripotent Stem Cells Using a Systematically Defined Culture Scheme.

Carpenedo RL, Kwon SY, Tanner RM, Yockell-Lelièvre J, Choey C, Doré C, Ho M, Stewart DJ, Perkins TJ, Stanford WL.

Stem Cell Reports. 2019 Dec 10;13(6):1111-1125. doi: 10.1016/j.stemcr.2019.11.001.

4.

A randomised, controlled, observer-masked trial of corneal cross-linking for progressive keratoconus in children: the KERALINK protocol.

Chowdhury K, Dore C, Burr JM, Bunce C, Raynor M, Edwards M, Larkin DFP.

BMJ Open. 2019 Sep 12;9(9):e028761. doi: 10.1136/bmjopen-2018-028761.

5.

Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic examination: a feasibility study.

Lewis C, Hutchinson JC, Riddington M, Hill M, Arthurs OJ, Fisher J, Wade A, Doré CJ, Chitty LS, Sebire NJ.

Health Technol Assess. 2019 Aug;23(46):1-104. doi: 10.3310/hta23460.

6.

Ophthalmic statistics note 13: method agreement studies in ophthalmology-please don't carry on correlating….

Bunce C, Stratton IM, Elders A, Czanner G, Doré C, Freemantle N; Ophthalmic Statistics Group.

Br J Ophthalmol. 2019 Sep;103(9):1201-1203. doi: 10.1136/bjophthalmol-2018-313759. Epub 2019 Jul 18. No abstract available.

7.

AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Leake PA, Rebscher SJ, Dore' C, Akil O.

J Assoc Res Otolaryngol. 2019 Aug;20(4):341-361. doi: 10.1007/s10162-019-00723-5. Epub 2019 Jun 20.

PMID:
31222416
8.

Assessing feasibility of routine identification tools for mental health disorder in neurology clinics.

Bennett SD, Heyman I, Coughtrey AE, Buszewicz M, Byford S, Dore CJ, Fonagy P, Ford T, Moss-Morris R, Stephenson T, Varadkar S, Walker E, Shafran R.

Arch Dis Child. 2019 Dec;104(12):1161-1166. doi: 10.1136/archdischild-2018-316595. Epub 2019 May 11.

PMID:
31079075
9.

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.

Hobbs AJ, Moyes AJ, Baliga RS, Ghedia D, Ochiel R, Sylvestre Y, Doré CJ, Chowdhury K, Maclagan K, Quartly HL, Sofat R, Smit A, Schreiber BE, Coghlan GJ, MacAllister RJ.

Br J Pharmacol. 2019 May;176(9):1251-1267. doi: 10.1111/bph.14621. Epub 2019 Mar 31.

PMID:
30761523
10.

A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspective.

Grynberg M, Murphy C, Doré C, Fresneau L, Paillet S, Petrica N, Frédérique M, Ravonimbola H.

J Med Econ. 2018 Nov 21:1-15. doi: 10.1080/13696998.2018.1551226. [Epub ahead of print]

PMID:
30461330
11.
12.

A water-processable cellulose-based resist for advanced nanofabrication.

Dore C, Osmond J, Mihi A.

Nanoscale. 2018 Sep 27;10(37):17884-17892. doi: 10.1039/c8nr04851g.

13.

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis.

Nguyen DX, Cotton A, Attipoe L, Ciurtin C, Doré CJ, Ehrenstein MR.

J Allergy Clin Immunol. 2018 Sep;142(3):978-980.e9. doi: 10.1016/j.jaci.2018.04.026. Epub 2018 Jun 20. No abstract available.

14.

Metformin Preconditioning of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery.

Ould-Brahim F, Sarma SN, Syal C, Lu KJ, Seegobin M, Carter A, Jeffers MS, Doré C, Stanford WL, Corbett D, Wang J.

Stem Cells Dev. 2018 Aug 15;27(16):1085-1096. doi: 10.1089/scd.2018.0055. Epub 2018 Jul 18.

PMID:
29893190
15.

Hydroxypropyl cellulose photonic architectures by soft nanoimprinting lithography.

Espinha A, Dore C, Matricardi C, Alonso MI, Goñi AR, Mihi A.

Nat Photonics. 2018 Jun;12(6):343-348. doi: 10.1038/s41566-018-0152-1. Epub 2018 Apr 9.

16.

Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset.

Lianga N, Doré C, Kennedy EK, Yeh E, Williams EC, Fortinez CM, Wang A, Bloom KS, Rudner AD.

PLoS Genet. 2018 Mar 21;14(3):e1007029. doi: 10.1371/journal.pgen.1007029. eCollection 2018 Mar.

17.

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E.

JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556.

18.

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

Ibrahim F, Lorente-Cánovas B, Doré CJ, Bosworth A, Ma MH, Galloway JB, Cope AP, Pande I, Walker D, Scott DL.

Rheumatology (Oxford). 2017 Nov 1;56(11):2004-2014. doi: 10.1093/rheumatology/kex315.

19.

[Self esteem : concept analysis.]

Doré C.

Rech Soins Infirm. 2017 Jun;(129):18-26. doi: 10.3917/rsi.129.0018. French.

PMID:
28956408
20.

Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

Julian LM, Delaney SP, Wang Y, Goldberg AA, Doré C, Yockell-Lelièvre J, Tam RY, Giannikou K, McMurray F, Shoichet MS, Harper ME, Henske EP, Kwiatkowski DJ, Darling TN, Moss J, Kristof AS, Stanford WL.

Cancer Res. 2017 Oct 15;77(20):5491-5502. doi: 10.1158/0008-5472.CAN-17-0925. Epub 2017 Aug 22.

21.

Ophthalmic statistics note 12: multivariable or multivariate: what's in a name?

Bunce C, Czanner G, Grzeda MT, Doré CJ, Freemantle N.

Br J Ophthalmol. 2017 Oct;101(10):1303-1305. doi: 10.1136/bjophthalmol-2017-310846. Epub 2017 Aug 16. No abstract available.

22.

Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.

Chen Z, Chang WY, Etheridge A, Strickfaden H, Jin Z, Palidwor G, Cho JH, Wang K, Kwon SY, Doré C, Raymond A, Hotta A, Ellis J, Kandel RA, Dilworth FJ, Perkins TJ, Hendzel MJ, Galas DJ, Stanford WL.

Aging Cell. 2017 Aug;16(4):870-887. doi: 10.1111/acel.12621. Epub 2017 Jun 8.

23.

Salvation Seeking or Death Avoidance?: Accounting for the Reluctant Consent.

Fanning JB, Dore CS.

Am J Bioeth. 2017 Feb;17(2):21-22. doi: 10.1080/15265161.2016.1265176. No abstract available.

PMID:
28112625
24.

Associations Between Clinical Evidence of Inflammation and Synovitis in Symptomatic Knee Osteoarthritis: A Cross-Sectional Substudy.

Wallace G, Cro S, Doré C, King L, Kluzek S, Price A, Roemer F, Guermazi A, Keen R, Arden N.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1340-1348. doi: 10.1002/acr.23162. Epub 2017 Aug 14.

25.

Ophthalmic statistics note 11: logistic regression.

Stephenson J, Bunce C, Doré CJ, Freemantle N; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Dec;100(12):1594-1595. doi: 10.1136/bjophthalmol-2016-309223. Epub 2016 Nov 3. No abstract available.

26.

The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.

Arden NK, Cro S, Sheard S, Doré CJ, Bara A, Tebbs SA, Hunter DJ, James S, Cooper C, O'Neill TW, Macgregor A, Birrell F, Keen R.

Osteoarthritis Cartilage. 2016 Nov;24(11):1858-1866. doi: 10.1016/j.joca.2016.05.020. Epub 2016 Jun 2.

27.

Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial.

Goldberg AJ, Zaidi R, Thomson C, Doré CJ, Skene SS, Cro S, Round J, Molloy A, Davies M, Karski M, Kim L, Cooke P; TARVA study group.

BMJ Open. 2016 Sep 6;6(9):e012716. doi: 10.1136/bmjopen-2016-012716.

28.

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

Cohen H, Hunt BJ, Efthymiou M, Arachchillage DR, Mackie IJ, Clawson S, Sylvestre Y, Machin SJ, Bertolaccini ML, Ruiz-Castellano M, Muirhead N, Doré CJ, Khamashta M, Isenberg DA; RAPS trial investigators.

Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5.

29.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

30.

Ophthalmic statistics note 10: data transformations.

Bunce C, Stephenson J, Doré CJ, Freemantle N; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Dec;100(12):1591-1593. doi: 10.1136/bjophthalmol-2016-308824. Epub 2016 Jul 18. No abstract available.

PMID:
27432738
31.

Results of a prepilot study of potential test material for the external quality assessment of reticulocyte haemoglobin content.

Hinchliffe RF, Mahon A, Thomas W, Doré CJ, Briggs C, De la Salle B, Hyde K.

Int J Lab Hematol. 2016 Aug;38(4):e86-8. doi: 10.1111/ijlh.12514. Epub 2016 Jun 16. No abstract available.

PMID:
27307309
32.

SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt.

Cho G, Anie KA, Buckton J, Kiilu P, Layton M, Alexander L, Hemmaway C, Sutton D, Amos C, Doré CJ, Kahan B, Meredith S.

BMJ Open. 2016 Jun 9;6(6):e011276. doi: 10.1136/bmjopen-2016-011276.

33.

Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition.

Kahan BC, Doré CJ, Murphy MF, Jairath V.

J Clin Epidemiol. 2016 Sep;77:38-43. doi: 10.1016/j.jclinepi.2016.05.008. Epub 2016 Jun 1.

PMID:
27262238
34.

Ophthalmic statistics note 9: parametric versus non-parametric methods for data analysis.

Skene SS, Bunce C, Freemantle N, Doré CJ; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Jul;100(7):877-878. doi: 10.1136/bjophthalmol-2015-308252. Epub 2016 Apr 27. No abstract available.

35.

Nutritional Evaluation and Optimisation in Neonates: a randomized, double-blind controlled trial of amino acid regimen and intravenous lipid composition in preterm parenteral nutrition.

Uthaya S, Liu X, Babalis D, Doré CJ, Warwick J, Bell J, Thomas L, Ashby D, Durighel G, Ederies A, Yanez-Lopez M, Modi N.

Am J Clin Nutr. 2016 Jun;103(6):1443-52. doi: 10.3945/ajcn.115.125138. Epub 2016 Apr 20.

36.

Chemical characteristics of a heteropolysaccharide from Tylopilus ballouii mushroom and its antioxidant and anti-inflammatory activities.

Lima AT, Santos MN, de Souza LA, Pinheiro TS, Paiva AA, Dore CM, Costa MS, Santos ND, Baseia YG, Araújo RM, Leite EL.

Carbohydr Polym. 2016 Jun 25;144:400-9. doi: 10.1016/j.carbpol.2016.02.050. Epub 2016 Feb 26.

PMID:
27083832
37.

Nutritional Evaluation and Optimisation in Neonates (NEON) trial of amino acid regimen and intravenous lipid composition in preterm parenteral nutrition: a randomised double-blind controlled trial.

Uthaya S, Liu X, Babalis D, Dore C, Warwick J, Bell J, Thomas L, Ashby D, Durighel G, Ederies A, Yanez-Lopez M, Modi N.

Southampton (UK): NIHR Journals Library; 2016 Mar.

38.

Ophthalmic statistics note 8: missing data--exploring the unknown.

Bunce C, Quartilho A, Freemantle N, Doré CJ; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Mar;100(3):291-4. doi: 10.1136/bjophthalmol-2015-307821. Epub 2015 Dec 30. No abstract available.

39.

Redundant Regulation of Cdk1 Tyrosine Dephosphorylation in Saccharomyces cerevisiae.

Kennedy EK, Dysart M, Lianga N, Williams EC, Pilon S, Doré C, Deneault JS, Rudner AD.

Genetics. 2016 Mar;202(3):903-10. doi: 10.1534/genetics.115.182469. Epub 2015 Dec 29.

40.

Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol.

Day AC, Burr JM, Bunce C, Doré CJ, Sylvestre Y, Wormald RP, Round J, McCudden V, Rubin G, Wilkins MR; FACT Group.

BMJ Open. 2015 Nov 27;5(11):e010381. doi: 10.1136/bmjopen-2015-010381.

41.

Competition between Heterochromatic Loci Allows the Abundance of the Silencing Protein, Sir4, to Regulate de novo Assembly of Heterochromatin.

Larin ML, Harding K, Williams EC, Lianga N, Doré C, Pilon S, Langis É, Yanofsky C, Rudner AD.

PLoS Genet. 2015 Nov 20;11(11):e1005425. doi: 10.1371/journal.pgen.1005425. eCollection 2015 Nov.

42.

A re-randomisation design for clinical trials.

Kahan BC, Forbes AB, Doré CJ, Morris TP.

BMC Med Res Methodol. 2015 Nov 5;15:96. doi: 10.1186/s12874-015-0082-2.

43.

A randomised controlled trial of flow driver and bubble continuous positive airway pressure in preterm infants in a resource-limited setting.

Mazmanyan P, Mellor K, Doré CJ, Modi N.

Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F16-20. doi: 10.1136/archdischild-2015-308464. Epub 2015 Aug 13.

PMID:
26271753
44.

Quantitative Maximum Shear-Wave Stiffness of Breast Masses as a Predictor of Histopathologic Severity.

Berg WA, Mendelson EB, Cosgrove DO, Doré CJ, Gay J, Henry JP, Cohen-Bacrie C.

AJR Am J Roentgenol. 2015 Aug;205(2):448-55. doi: 10.2214/AJR.14.13448.

PMID:
26204299
45.

Ophthalmic statistics note 7: multiple hypothesis testing—to adjust or not to adjust.

Cipriani V, Quartilho A, Bunce C, Freemantle N, Doré CJ; Ophthalmic Statistics Group.

Br J Ophthalmol. 2015 Sep;99(9):1155-7. doi: 10.1136/bjophthalmol-2015-306784. Epub 2015 Jun 25. No abstract available.

46.

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Lancet. 2015 Jul 11;386(9989):137-44. doi: 10.1016/S0140-6736(14)61999-1. Epub 2015 May 5.

PMID:
25956718
47.

Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.

Cohen H, Doré CJ, Clawson S, Hunt BJ, Isenberg D, Khamashta M, Muirhead N; RAPS Trial Protocol Collaborators.

Lupus. 2015 Sep;24(10):1087-94. doi: 10.1177/0961203315581207. Epub 2015 May 4.

48.

A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years.

Marlow N, Morris T, Brocklehurst P, Carr R, Cowan F, Patel N, Petrou S, Redshaw M, Modi N, Doré CJ.

Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F320-6. doi: 10.1136/archdischild-2014-307410. Epub 2015 Apr 28.

49.

[SIPPE. How to maintain the loyalty of the families to the program?].

Guay A, Bell L, Doré C, Gallagher F.

Perspect Infirm. 2015 Mar-Apr;12(2):55-7. French. No abstract available.

PMID:
25850230
50.

Ophthalmic statistics note 6: effect sizes matter.

Cook JA, Bunce C, Doré CJ, Freemantle N; Ophthalmic Statistics Group.

Br J Ophthalmol. 2015 May;99(5):580-1. doi: 10.1136/bjophthalmol-2014-306303. Epub 2015 Feb 26. No abstract available.

Supplemental Content

Support Center